Skip to main content
No access
Articles
Published Online: 29 November 2023

The Long-Term Relationship Between Cannabis and Heroin Use: An 18- to 20-year Follow-Up of the Australian Treatment Outcome Study (ATOS)

Publication: American Journal of Psychiatry

Abstract

Objective:

Cannabis use is common among individuals with opioid use disorder, but it remains unclear whether cannabis use is associated with an increase or a reduction in illicit opioid use. To overcome limitations identified in previous longitudinal studies with limited follow-ups, the authors examined a within-person reciprocal relationship between cannabis and heroin use at several follow-ups over 18 to 20 years.

Methods:

The Australian Treatment Outcome Study (ATOS) recruited 615 people with heroin dependence in 2001 and 2002 and reinterviewed them at 3, 12, 24, and 36 months as well as 11 and 18–20 years after baseline. Heroin and cannabis use were assessed at each time point using the Opiate Treatment Index. A random-intercept cross-lagged panel model analysis was conducted to identify within-person relationships between cannabis use and heroin use at subsequent follow-ups.

Results:

After accounting for a range of demographic variables, other substance use, and mental and physical health measures, an increase in cannabis use 24 months after baseline was significantly associated with an increase in heroin use at 36 months (estimate=0.21, SE=0.10). Additionally, an increase in heroin use at 3 months and 24 months was significantly associated with a decrease in cannabis use at 12 months (estimate=−0.27, SE=0.09) and 36 months (estimate=−0.22, SE=0.08). All other cross-lagged associations were not significant.

Conclusions:

Although there was some evidence of a significant relationship between cannabis and heroin use at earlier follow-ups, this was sparse and inconsistent across time points. Overall, there was insufficient evidence to suggest a unidirectional or bidirectional relationship between the use of these substances.

Get full access to this article

View all available purchase options and get full access to this article.

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 135 - 143
PubMed: 38018142

History

Received: 2 February 2023
Revision received: 15 June 2023
Accepted: 21 July 2023
Published online: 29 November 2023
Published in print: February 01, 2024

Keywords

  1. Substance-Related and Addictive Disorders
  2. Opioids
  3. Cannabis
  4. Addiction Psychiatry

Authors

Details

Jack Wilson, Ph.D. [email protected]
Matilda Centre for Research in Mental Health and Substance Use, University of Sydney, Sydney, Australia (Wilson, Mills, Sunderland, Teesson, Marel); Addiction and Mental Health Group, University of Bath, Bath, U.K. (Freeman); Sydney Medical School, University of Sydney, Sydney, Australia (Haber); Drug Health Services, Royal Prince Alfred Hospital, Camperdown, Australia (Haber).
Katherine L. Mills, Ph.D.
Matilda Centre for Research in Mental Health and Substance Use, University of Sydney, Sydney, Australia (Wilson, Mills, Sunderland, Teesson, Marel); Addiction and Mental Health Group, University of Bath, Bath, U.K. (Freeman); Sydney Medical School, University of Sydney, Sydney, Australia (Haber); Drug Health Services, Royal Prince Alfred Hospital, Camperdown, Australia (Haber).
Matthew Sunderland, Ph.D.
Matilda Centre for Research in Mental Health and Substance Use, University of Sydney, Sydney, Australia (Wilson, Mills, Sunderland, Teesson, Marel); Addiction and Mental Health Group, University of Bath, Bath, U.K. (Freeman); Sydney Medical School, University of Sydney, Sydney, Australia (Haber); Drug Health Services, Royal Prince Alfred Hospital, Camperdown, Australia (Haber).
Tom P. Freeman, Ph.D.
Matilda Centre for Research in Mental Health and Substance Use, University of Sydney, Sydney, Australia (Wilson, Mills, Sunderland, Teesson, Marel); Addiction and Mental Health Group, University of Bath, Bath, U.K. (Freeman); Sydney Medical School, University of Sydney, Sydney, Australia (Haber); Drug Health Services, Royal Prince Alfred Hospital, Camperdown, Australia (Haber).
Maree Teesson, Ph.D.
Matilda Centre for Research in Mental Health and Substance Use, University of Sydney, Sydney, Australia (Wilson, Mills, Sunderland, Teesson, Marel); Addiction and Mental Health Group, University of Bath, Bath, U.K. (Freeman); Sydney Medical School, University of Sydney, Sydney, Australia (Haber); Drug Health Services, Royal Prince Alfred Hospital, Camperdown, Australia (Haber).
Paul S. Haber, M.D., Ph.D.
Matilda Centre for Research in Mental Health and Substance Use, University of Sydney, Sydney, Australia (Wilson, Mills, Sunderland, Teesson, Marel); Addiction and Mental Health Group, University of Bath, Bath, U.K. (Freeman); Sydney Medical School, University of Sydney, Sydney, Australia (Haber); Drug Health Services, Royal Prince Alfred Hospital, Camperdown, Australia (Haber).
Christina Marel, Ph.D.
Matilda Centre for Research in Mental Health and Substance Use, University of Sydney, Sydney, Australia (Wilson, Mills, Sunderland, Teesson, Marel); Addiction and Mental Health Group, University of Bath, Bath, U.K. (Freeman); Sydney Medical School, University of Sydney, Sydney, Australia (Haber); Drug Health Services, Royal Prince Alfred Hospital, Camperdown, Australia (Haber).

Notes

Send correspondence to Dr. Wilson ([email protected]).

Competing Interests

Dr. Haber has received research funding from Indivior. The other authors report no financial relationships with commercial interests.

Funding Information

This work was funded by the Australian National Health and Medical Research Council (NHMRC) (Project Grant APP1147212) and was supported by an NHMRC Ph.D. scholarship awarded to Dr. Wilson and NHMRC Fellowships to Dr. Marel, Dr. Mills, Dr. Haber, and Dr. Teesson. The project was also supported by Matilda Centre funding.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

View options

PDF/EPUB

View PDF/EPUB

Full Text

View Full Text

Media

Figures

Other

Tables

Share

Share

Share article link

Share